Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Samaiden Group Berhad Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Samaiden Group Berhad şirketinin toplam hissedar öz sermayesi MYR134.6M ve toplam borcu MYR8.5M olup, bu da borç-öz sermaye oranını 6.3% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla MYR205.1M ve MYR70.5M dir. Samaiden Group Berhad 'in FAVÖK'ü MYR23.5M faiz karşılama oranı 14.6 dur. Şirketin MYR126.9M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

6.3%

Borç/özkaynak oranı

RM 8.45m

Borç

Faiz karşılama oranı	14.6x
Nakit	RM 126.93m
Eşitlik	RM 134.61m
Toplam yükümlülükler	RM 70.49m
Toplam varlıklar	RM 205.10m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

There May Be Underlying Issues With The Quality Of Samaiden Group Berhad's (KLSE:SAMAIDEN) Earnings

Sep 05

New Forecasts: Here's What Analysts Think The Future Holds For Samaiden Group Berhad (KLSE:SAMAIDEN)

May 29

We Don’t Think Samaiden Group Berhad's (KLSE:SAMAIDEN) Earnings Should Make Shareholders Too Comfortable

Mar 04

Samaiden Group Berhad's (KLSE:SAMAIDEN) Popularity With Investors Is Under Threat From Overpricing

Jan 15

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: SAMAIDEN 'nin kısa vadeli varlıkları ( MYR197.2M ) kısa vadeli yükümlülüklerini ( MYR66.9M ) aşıyor.

Uzun Vadeli Yükümlülükler: SAMAIDEN şirketinin kısa vadeli varlıkları ( MYR197.2M ) uzun vadeli yükümlülüklerini ( MYR3.6M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: SAMAIDEN şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: SAMAIDEN şirketinin borç/öz sermaye oranı son 5 yılda 0.2% seviyesinden 6.3% seviyesine yükseldi.

Borç Kapsamı: SAMAIDEN 'nin borcu işletme nakit akışı ( 16.8% ) tarafından iyi bir şekilde karşılanmıyor.

Faiz Kapsamı: SAMAIDEN 'in borcuna ilişkin faiz ödemeleri EBIT ( 14.6 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

Samaiden Group Berhad Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

There May Be Underlying Issues With The Quality Of Samaiden Group Berhad's (KLSE:SAMAIDEN) Earnings

Dividend of RM0.007 announced

Full year 2024 earnings: EPS and revenues miss analyst expectations

Samaiden Group Berhad Announces the Resignation of Kuan Hui Fang as Joint Company Secretary

Samaiden Group Berhad (KLSE:SAMAIDEN) Not Flying Under The Radar

New minor risk - Market cap size

Investor sentiment deteriorates as stock falls 16%

Consensus EPS estimates fall by 13%

Samaiden Group Berhad Announces Resignation of Foo Jen Kah as Chief Financial Officer, Effective April 20, 2024

Consensus EPS estimates fall by 11%

Now 20% overvalued after recent price rise

Samaiden Group Berhad Announces the Appointment of Puan Sri Datuk Seri Rohani Parkash Binti Abdullah as Independent and Non Executive Member of Risk Committee

Samaiden Group Berhad Appoints Puan Sri Datuk Seri Rohani Parkash Binti Abdullah as Independent and Non Executive Chairman of Nomination Committee

Second quarter 2024 earnings released: EPS: RM0.007 (vs RM0.007 in 2Q 2023)

Samaiden Group Berhad Announces Appointment of Olivia Lim as Independent and Non Executive Member of Risk Committee

Samaiden Group Berhad Announces Promotion of Ir Lim Kein Seng from Technical Director to Chief Technical Officer

First quarter 2024 earnings released: EPS: RM0.008 (vs RM0.006 in 1Q 2023)

Samaiden Group Berhad Announces Resignation of Fong Sok Yee as Joint Secretary

New minor risk - Market cap size

Price target increased by 12% to RM1.45

Full year 2023 earnings released: EPS: RM0.026 (vs RM0.032 in FY 2022)

Is There Now An Opportunity In Samaiden Group Berhad (KLSE:SAMAIDEN)?

New minor risk - Shareholder dilution

Now 21% undervalued

Samaiden Group Berhad Appoints Fong Sok Yee as Joint Secretary

Price target increased by 13% to RM1.20

Investor sentiment improves as stock rises 17%

Some Analysts Just Cut Their Samaiden Group Berhad (KLSE:SAMAIDEN) Estimates

Third quarter 2023 earnings released: EPS: RM0.005 (vs RM0.012 in 3Q 2022)

Second quarter 2023 earnings released: EPS: RM0.007 (vs RM0.006 in 2Q 2022)

Price target increased by 16% to RM0.98

Samaiden Group Berhad, Annual General Meeting, Dec 09, 2022

Samaiden Group Berhad Announces Appointment of Foo Jen Kah as Chief Financial Officer

First quarter 2023 earnings released: EPS: RM0.006 (vs RM0.006 in 1Q 2022)

High number of new and inexperienced directors

Samaiden Group Berhad Announces Resignation of Chong Kim Soong as Chief Financial Officer

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to RM0.87

New Forecasts: Here's What Analysts Think The Future Holds For Samaiden Group Berhad (KLSE:SAMAIDEN)

Third quarter 2022 earnings released: EPS: RM0.02 (vs RM0.009 in 3Q 2021)

High number of new and inexperienced directors

Investor sentiment improved over the past week

We Don’t Think Samaiden Group Berhad's (KLSE:SAMAIDEN) Earnings Should Make Shareholders Too Comfortable

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

High number of new and inexperienced directors

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS RM0.031 (vs RM0.049 in FY 2020)

Samaiden Group Berhad Announces Appointment of Chong Kim Soong as Chief Financial Officer

New 90-day high: RM1.72

Investor sentiment improved over the past week

Samaiden Group Berhad's (KLSE:SAMAIDEN) Popularity With Investors Is Under Threat From Overpricing

Samaiden Group Berhad Announces Resignation of Susie Chung Kim Lan as Chief Financial Officer

Investor sentiment improved over the past week

Market bids up stock over the past week

Market bids up stock over the past week

Samaiden Group Berhad has completed an IPO in the amount of MYR 29.3544 million.

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin